Electric-Field Molecular Fingerprinting to Probe Cancer.
ACS Cent Sci 2025; 11(4): 560-573;
Kepesidis KV, Jacob P, Schweinberger W, Huber M, Feiler N, Fleischmann F, Trubetskov M, Voronina L, Aschauer J, Eissa T, Gigou L, Karandušovsky P, Pupeza I, Weigel A, Azzeer A, Stief CG, Chaloupka M, Reinmuth N, Behr J, Kolben T, Harbeck N, Reiser M, Krausz F, Žigman M

[Molecular Tumour Boards for Urological Tumours: Hope or Disappointment?].
Aktuelle Urol 2025;
Gaisa NT, Eckstein M, Casuscelli J, Kalogirou C, Zschäbitz S, Dörffer N, Reis H

Infrared Spectroscopic Profiling of Volatile Metabolites from Uropathogenic Bacteria: Basic Investigations toward Rapid UTI Diagnostics.
Anal Chem 2025; 97(39): 21449-21458;
Maiti KS, Roy S, Zenner C, J Hall L, Hauer J, Sroka R

Measurement of Bacterial Headspaces by FT-IR Spectroscopy Reveals Distinct Volatile Organic Compound Signatures.
Anal Chem 2025; 97(1): 106-113;
Zenner C, Hall LJ, Roy S, Hauer J, Sroka R, Maiti KS

Low-intensity shockwave therapy for erectile dysfunction due to diabetes mellitus or coronary artery disease: An individual participant data meta-analysis from a single center.
Andrology 2025;
Pyrgidis N, Kalyvianakis D, Mykoniatis I, Hatzichristou D

The effect of topical and intraurethral alprostadil on erectile function: A systematic review and meta-analysis.
Andrology 2025; 13(8): 2235-2245;
Papadopoulos I, Tishukov M, Sokolakis I, Katafigiotis I, Leotsakos I, Karavitakis M, Marcon J, Stief CG, Pyrgidis N

Global comparison of research ethical review protocols: insights from an international research collaborative.
BJU Int 2025; 135(5): 717-719;
Chow BJ, Light A, Nathan A, Baekelandt L, Marcq G, Croghan S, Gaba F, Esperto F, Orecchia L, Toribio-Vázquez C, Gómez Rivas J, Fung AC, Gebreselassie KH, Felicio E, Danurdoro A, Pyrgidis N, Marko V, Svihra J, Javid M, Salas A, Thanh TT, Alexander C, Bhatt N, Khadhouri S, Kasivisvanathan V, Byrnes K, British Urology Researchers in Surgical Training (BURST) in collaboration with the European Association of Urology Young Academic Urologists Urothelial Carcinoma Working Group

Peri-operative outcomes of open, laparoscopic and robotic simple prostatectomy.
BJU Int 2025; 136(6): 1107-1113;
Pyrgidis N, Weinhold P, Schulz GB, Atzler M, Stadelmeier LF, Papadopoulos I, Stief C, Marcon J, Keller P

Perioperative complications of focal therapy for prostate cancer: results from the GeRmAn Nationwide inpatient Data (GRAND) study.
BJU Int 2025; 136(2): 306-313;
Pyrgidis N, Chaloupka M, Ebner B, Volz Y, Weinhold P, Marcon J, Eismann L, Stief CG, Schulz GB, Apfelbeck M

Response to "Comment on 'Peri-operative outcomes of open, laparoscopic and robotic simple prostatectomy'".
BJU Int 2025;
Pyrgidis N, Weinhold P, Schulz GB, Atzler M, Stadelmeier LF, Papadopoulos I, Stief C, Marcon J, Keller P

Radiomics-based differentiation of upper urinary tract urothelial and renal cell carcinoma in preoperative computed tomography datasets.
BMC Med Imaging 2025; 25(1)
Marcon J, Weinhold P, Rzany M, Fabritius MP, Winkelmann M, Buchner A, Eismann L, Jokisch JF, Casuscelli J, Schulz GB, Knösel T, Ingrisch M, Ricke J, Stief CG, Rodler S, Kazmierczak PM

Exercise oncology in prostate cancer: from observational insight to prescriptive precision.
Br J Cancer 2025; 133(8): 1074-1075;
May M, Gilfrich C, Enzinger B, Brookman-May S

PSMA expression assessed by [18F]PSMA-1007 PET/CT imaging in metastatic hormone-sensitive prostate cancer patients treated with apalutamide.
Cancer Imaging 2025; 25(1)
Berg EK, Kunte SC, Zahner J, Holzgreve A, Aydogdu CD, Schmid HP, Eismann L, Rodler S, Unterrainer M, Werner RA, Stief CG, Unterrainer LM, Casuscelli J

Changes of Prostate-Specific Membrane Antigen-Radioligand Uptake on PET with Systemic Therapy in Patients with Metastatic Renal Cell Carcinoma.
Cancers (Basel) 2025; 17(11)
Kunte SC, Holzgreve A, Unterrainer M, Zahner J, Schmid HP, Schöll M, Blajan I, Sheikh GT, Mehrens D, Casuscelli J, Tamalunas AJ, Werner RA, Stief CG, Staehler M, Unterrainer LM

Expression Profiles of Co-Inhibitory Receptors in Non-Urothelial Bladder Cancer: Preclinical Evidence for the Next Generation of Immune Checkpoint Inhibitors.
Cancers (Basel) 2025; 17(13)
Rodler S, Ledderose ST, Waidelich R, Kohler J, Sendelhofert A, Casuscelli J, Schulz G, Stief CG, Eismann L

Perioperative Outcomes After Radical Nephrectomy with Inferior Vena Cava Thrombectomy.
Cancers (Basel) 2025; 17(7)
Pyrgidis N, Schulz GB, Stief CG, Blajan I, Ivanova T, Graser A, Staehler M

Testicular Cancer Education-Hidden Potential Ways to Improve Awareness and Early Diagnosis in Young Men?
Children (Basel) 2025; 12(10)
Kidess M, Goedeke J, Aschl F, Pyrgidis N, Volz Y, Georgieva T, Stredele R, Ebner B, Atzler M, Askari D, Heinrich M, Becker K, Hermans J, Marcon J, Apfelbeck M, Muensterer O, Stief CG, Chaloupka M

A Prospective Non-interventional Real-World Study of cabozantinib in Pretreated Patients With Advanced Renal Cell Carcinoma Refractory to Vascular Endothelial Growth Factor-Targeted Therapy (CASSIOPE).
Clin Genitourin Cancer 2025; 23(1)
Staehler M, Basso U, Eymard JC, Barthelemy P, Bigot P, Laramas M, Rink M, Suarez C, Guillot A, Bedke J, Hamberg P, De Vivo R, Gajate P, Lázaro-Quintela M, Rastogi P, Perrot V, Qvick B, Dutailly P, Verzoni E, Procopio G

Clinical Management of Synchronous and Metachronous Renal Lesions in Patients With Oncocytoma Treated With Nephrectomy: A 30-Year Single-Center Experience.
Clin Genitourin Cancer 2025;
Eismann L, Reese SW, Dawidek MT, Calderon LP, Aulitzky A, Vazquez-Rivera K, Coleman JA, Stief CG, Reznik E, Russo P, Hakimi AA

Comparative Impact of Microsurgical Varicocelectomy Versus Observation on Infertility in Infertile Men With Subclinical Varicocele.
Cureus 2025; 17(1)
Sountoulides P, Pyrgidis N, Kaltsas A, Gravas S, Kikidakis D, Zachos I, Zachariou A, Dimitriadis F, Sofikitis N

Renal Cell Carcinoma: Prognosis in the Era of Targeted Therapy.
Curr Oncol 2025; 32(9)
Halfter K, Staehler M, Hölzel D, Crispin A, Schlesinger-Raab A

Adverse Pathology After Radical Prostatectomy in Low- and Intermediate-Risk Prostate Cancer: A Propensity Score-Matched Analysis of Long-Term Health-Related Quality of Life.
Diagnostics 2025; 15(15):1969;
Chaloupka M, Buchner A, Kidess M, Ebner B, Volz Y, Pyrgidis N, Ledderose ST, Clevert D-A, Marcon J, Weinhold P, Stief CG, Apfelbeck M

Feasibility and Safety of Primary Ureteroscopy with Single-Use Flexible Ureteroscope HU30M (6.3 Fr, HugeMed): An Initial Experience.
Diagnostics (Basel) 2025; 15(19)
Ebner B, Blajan I, Westphal JR, Papadopoulos I, Ivanova T, Karatas D, Happe M, Volz Y, Stief CG, Apfelbeck M, Chaloupka M

Prognostic Value of Automated Bone Scan Index (aBSI) in Patients with mCRPC Undergoing Three vs. Six Cycles of 223Ra Therapy.
Diagnostics (Basel) 2025; 15(16)
Siegmund SC, Ilhan H, Gerull A, Todica A, Unterrainer M, Delker A, Gildehaus FJ, Aydogdu CD, Stief CG, Werner RA, Unterrainer LM, Zacherl MJ

Microbiome landscapes of the bladder, intestine, and vagina in bladder cancer: a systematic review.
Discov Oncol 2025; 16(1)
Surber J, Semmler M, Enderlin D, Affentranger A, Scherer T, Sigg S, Kaufmann E, Gadient J, Truscello L, Scharl M, Morsy Y, Eberli D, Poyet C, Bieri U

Trends and Perioperative Outcomes of Pediatric Urological Procedures: Findings of the GRAND Study.
Dtsch Arztebl Int 2025; 122(7): 193-194;
Pyrgidis N, Stredele R, Schulz GB, Chaloupka M, Ebner B, Ivanova T, Atzler M, Pfitzinger PL, Weinhold P, Stief CG, Marcon J

RECIP 1.0 + PSA for response assessment in mCRPC patients treated with 225Ac / 177Lu PSMA combination therapy.
EJNMMI Res 2025; 15(1)
Sheikh GT, Delker A, Zacherl MJ, Holzgreve A, Takayama Fouladgar SL, Unterrainer M, Rübenthaler J, Casuscelli J, Gafita A, Unterrainer LM

[18F]F-FAPI-74 PET/CT for gonadal and extragonadal germ cell Tumors: a pilot study.
EJNMMI Res 2025;
Kidess M, Siegmund SC, Unterrainer LM, Kazmierczak P, Hentrich M, Eismann L, Volz Y, Ebner B, Hermans J, Pyrgidis N, Apfelbeck M, Sheikh GT, Werner RA, Klauschen F, Stief CG, Ledderose ST, Chaloupka M

68Ga-FAPI and 18F-FAPI PET/CT for detection of nodal metastases prior radical cystectomy in high-risk urothelial carcinoma patients.
Eur J Nucl Med Mol Imaging 2025; 52(11): 3963-3974;
Unterrainer LM, Schmid HP, Kunte SC, Holzgreve A, Toms J, Menold P, Cyran CC, Karl A, Tschirdewahn S, Ledderose ST, Eismann L, Tamalunas AJ, Scheifele M, Stief CG, Unterrainer M, Casuscelli J, Schulz GB

Potential value of [68Ga]Ga-FAPI-46 PET in patients with metastatic urothelial carcinoma: a bi-centric analysis.
Eur J Nucl Med Mol Imaging 2025;
Pabst KM, Siegmund SC, Holzgreve A, Schmid HP, Bartel T, Herrmann K, Küper AT, Aydogdu C, Kersting D, Kesch C, Hadaschik BA, Unterrainer M, Stief CG, Cyran CC, Werner RA, Fendler WP, Casuscelli J, Unterrainer LM

Refining the clinical utility of [177Lu]Lu/[225Ac]Ac-PSMA tandem RLT in patients with metastatic castration resistant prostate cancer.
Eur J Nucl Med Mol Imaging 2025;
Widjaja L, Hornfeck J, Siegmund SC, Gildehaus FJ, Schmidt-Hegemann NS, Wenter V, Sheikh GT, Klimek K, Casuscelli J, Stief CG, Zacherl MJ, Werner RA

[99mTc]Tc-antigranulocyte scintigraphy for prediction of bone marrow reserve prior to radioligand therapy in patients with metastatic castration resistant prostate cancer.
Eur J Nucl Med Mol Imaging 2025; 52(12): 4446-4455;
Kunte SC, Delker A, Holzgreve A, Zacherl MJ, Scheifele M, Casuscelli J, Gildehaus FJ, Unterrainer M, Ilhan H, Werner RA, Unterrainer LM

Defining the Histopathological, Clinical, and Genetic Characteristics of Familial BAP1-associated Renal Cell Carcinoma.
Eur Urol 2025; 88(6): 630-632;
Posada Calderon L, Dawidek MT, Tang C, Kim M, Zong G, Bandlamudi C, Mehine M, Sheikh R, Kemel Y, Eismann L, Ganz M, Barbakoff D, Byrne L, Gray I, Nethala D, Rathi N, Vocke CD, Liu YL, Latham A, Stadler ZK, Offit K, Coleman JA, Goh AC, Russo P, Reznik E, Motzer RJ, Chen YB, Linehan WM, Reuter VE, Abdel-Rahman MH, Ball MW, Hakimi AA, Carlo MI

Sample Site Impacts RNA Biomarkers for Renal Cell Carcinoma.
Eur Urol 2025; 87(1): 79-83;
Eismann L, Xie AX, Tang C, Knezevic A, Ostrovnaya I, Kuo F, Ari Hakimi A, Reznik E, Kotecha RR

Evolution of Robotic Urology in Clinical Practice from the Beginning to Now: Results from the GRAND Study Register.
Eur Urol Focus 2025; 11(1): 109-117;
Pyrgidis N, Volz Y, Ebner B, Westhofen T, Staehler M, Chaloupka M, Apfelbeck M, Jokisch F, Bischoff R, Marcon J, Weinhold P, Becker A, Stief C, Schulz GB

Gender Disparities in Health-related Quality of Life Outcomes Following Radical Cystectomy for Bladder Cancer.
Eur Urol Focus 2025;
Westhofen T, Eismann L, Schulz GB, Bauer RM, Waidelich R, Casuscelli J, Berg E, Blajan I, Götz M, Brinkmann I, Coleman J, Shahbaz-Stöcker W, Mehrens D, Buchner A, Karl A, Schlenker B, Becker A, Stief CG, Rodler S, Kretschmer A

Oncologic Outcomes of Template Versus Radioguided Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography Scan: Results from a Multi-institutional Collaboration.
Eur Urol Focus 2025; 11(6): 921-925;
Bravi CA, Knipper S, Heidenreich A, Fossati N, Gandaglia G, Dell'Oglio P, Suardi N, Osmonov D, Juenemann KP, Karnes J, Kretschmer A, Budäus L, Falkenbach F, Buchner A, Stief C, Hiester A, Albers P, Devos G, Joniau S, Poppel HV, Grubmüller B, Shariat S, Pfister D, Tilki D, Graefen M, Gill IS, Mottrie A, Montorsi F, Briganti A, Maurer T

The Role of Salvage Cystectomy After Prior Trimodality Therapy: A Multinational Match-paired Analysis.
Eur Urol Focus 2025;
Pyrgidis N, Schulz GB, Scilipoti P, Pellegrino F, Casuscelli J, Tzelves L, Katsimperis S, Ciavarella D, Mir MC, Sokolakis I, Klatte T, Belinchon AR, Velasco JC, Fujii Y, Tanaka H, Yoshida S, Matsumoto S, Umari P, Teoh JY, Ming CWH, Simone G, Mastroianni R, Mayr R, Giudice FD, Moschini M

Trends and Perioperative Outcomes of Surgical Treatments for Benign Prostatic Hyperplasia in Germany: Results from the GRAND Study.
Eur Urol Focus 2025; 11(3): 463-470;
Marcon J, Keller P, Pyrgidis N, Atzler M, Kidess M, Götz M, Jokisch JF, Chaloupka M, Stief CG, Schulz GB, Weinhold P

Multiregional Immune Profiling Reveals Prognostic Patterns in Bladder Cancer.
Eur Urol Oncol 2025;
Jurczok N, Dernbach G, Ebner B, Plage H, Dragomir MP, Keyl P, Ribbat-Idel J, Ramberger E, Roßner F, Quaas A, Sauter G, Schlomm T, Klauschen F, Stief C, Horst D, Schulz GB, Eich ML, Schallenberg S

Risk of Biochemical Recurrence and Metastasis in Prostate Cancer Patients Treated with Radical Prostatectomy After a 10-year Disease-free Interval.
Eur Urol Oncol 2025; 8(2): 372-379;
Hoeh B, Preisser F, Zattoni F, Kretschmer A, Westhofen T, Olivier J, Soeterik TFW, van den Bergh RCN, Mandel P, Graefen M, Tilki D, EAU-YAU Prostate Cancer Working Group

Next-generation Solutions: Are Patients Ready for Electronic Artificial Urinary Sphincters for Male Incontinence?
Eur. Urol. Open Sci. 2025; 74(): 21-27;
Kidess M, Ivanova T, Hermans J, Stadelmeier L, Hoffmann M, Pyrgidis N, Marcon J, Chaloupka M, Bauer RM, Stief CG, Volz Y

Prevalence and Prognostic Significance of Preoperative Anemia in Radical Cystectomy Patients: A Multicenter Retrospective Observational Study.
Eur. Urol. Open Sci. 2025; 77(): 10-18;
Kaufmann E, Antonelli L, Afferi L, Asero V, Prata F, Rebuffo S, Veccia A, Culpan M, Tully K, Ribeiro L, Roumeguere T, Hendricksen K, Lambertini L, Pichler R, Pavan N, Teoh JY, Roumiguié M, Schulz GB, Soria F, AlGhamlas A, Desprez PE, Orecchia L, Poyet C, Alrumayyan M, Rink M, Zamboni S, Montes MR, Okoye S, Re ML, Krajewski W, Lavallee L, Wettstein MS, Moschini M, Fankhauser CD

Real-world Evidence from a Retrospective Multicentre Analysis on First-line Therapy for Metastatic Papillary Renal Cell Carcinoma. A GUARDIANS Project.
Eur. Urol. Open Sci. 2025; 78(): 59-67;
Hilser T, Casuscelli J, Aydogdu C, Zschäbitz S, Schnabel MJ, Rinderknecht E, Mattigk A, Schostak M, Volk AL, Ivanyi P, Wiegmann J, Darr C, Flegar L, Mandal S, Schlack K, Seidl D, Handke A, Klee M, Nestler T, Rehlinghaus M, Hijazi S, Heidenreich A, Grünwald V, Paffenholz P

Targeting All Multiple Magnetic Resonance Imaging Prostate Lesions Does Not Enhance Cancer Detection: Insights from the YAU Prostate Cancer Group.
Eur. Urol. Open Sci. 2025; 75(): 61-68;
Zattoni F, Gandaglia G, Marra G, Carletti F, Kasivisvanathan V, Ploussard G, Fazekas T, Martini A, Olivier J, Chiu PK, Valerio M, Marquis A, Gontero P, Guo H, Zhuang J, Barletta F, Leni R, Cirulli G, Kretschmer A, Apfelbeck M, Kesch C, Rajwa P, Giganti F, den Bergh RV, Dal Moro F, Briganti A, Novara G, EAU-YAU Prostate Cancer Working Party

Acridocarpus smeathmannii root extracts inhibit human prostate and bladder smooth muscle contraction, porcine arterial vasoconstriction, and cytotoxicity of prostate stromal cells.
Front Pharmacol 2025;
Kale OE, Hu S, Huber C, Schierholz F, Ciotkowska A, Tamalunas A, Stief CG, Eisenreich W, Hennenberg M

Voiding symptom severity varies independently from non-adrenergic prostate smooth muscle contractions in patients undergoing surgery for benign prostatic hyperplasia.
Front Physiol 2025;
Keller P, Hu S, Nicola P, Berger L, Tamalunas A, Weinhold P, Stief CG, Hennenberg M

Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the CLEAR trial.
Int J Cancer 2025; 156(7): 1326-1335;
Grünwald V, McKay RR, Buchler T, Eto M, Park SH, Takagi T, Zanetta S, Keizman D, Suárez C, Négrier S, Lee JL, Santini D, Bedke J, Staehler M, Kollmannsberger C, Choueiri TK, Motzer RJ, Burgents JE, Xie R, Okpara CE, Powles T

Head-to-head comparison of TKI and CPI first-line treatment strategies in advanced renal cell carcinoma-Real-world data from the German research platform CARAT.
Int J Cancer 2025;
Goebell PJ, Bögemann M, Nusch A, Grünwald V, Müller L, von der Heyde E, Martens UM, Lennartz C, Koska M, Potthoff K, Kaiser-Osterhues A, Grüllich C, Staehler M, Jänicke M, Marschner D, CARAT Registry Group

Real-world efficacy and toxicity of ipilimumab and nivolumab as a first-line treatment for advanced renal cell carcinoma according to IMDC risk criteria-A multi-center retrospective analysis on behalf of the GUARDIANS group.
Int J Cancer 2025;
Dinkel H, Materna L, Stelmach R, Zschäbitz S, Neuberger S, Aydogdu CD, Casuscelli J, Egenolf T, Silberg M, Steinestel J, Strauss A, Kirchhoff F, Ahrens M, Paffenholz P, Cathomas R, Özdemir BC, Gossler C, Ivanyi P, Rehlinghaus M, Hilser T, Grünwald V, Schlack K

The perioperative outcomes of retroperitoneal lymph node dissection in Germany for patients with testicular cancer: Results from the GRAND study.
Int J Cancer 2025; 157(7): 1333-1341;
Pyrgidis N, Apfelbeck M, Kidess M, Weinhold P, Marcon J, Schulz GB, Volz Y, Ebner B, Sparwasser PM, Tsaur I, Hentrich M, Stief CG, Chaloupka M

The recommended treatment protocol for low-intensity shockwave therapy based on the severity of erectile dysfunction.
Int J Impot Res 2025; 37(7): 566-568;
Pyrgidis N, Kalyvianakis D, Mykoniatis I, Hatzichristou D

Efficacy of SABR in Uncommon Subtypes of Primary Kidney Cancer: An Analysis From the International Radiosurgery Oncology Consortium of the Kidney.
Int J Radiat Oncol Biol Phys 2025;
Ali M, Correa RJM, Pryor D, Higgs B, Sridharan S, Sidhom M, Muacevic A, Onishi H, Swaminath A, Grubb W, Yang DX, Grant A, Morgan SC, Ponsky L, Cury FL, Teh BS, Lo SS, Mahadevan A, Kaplan ID, Chu W, Hannan R, Staehler M, Zaorsky NG, Warner A, Louie AV, Siva S

Shining a Light on the Future of Biophotonics.
J Biophotonics 2025; 18(7)
Baldini F, Dholakia K, French P, Guntinas-Lichius O, Kohler A, Mäntele W, Marcu L, Sroka R, Umapathy S, Popp J

Comparison of Perioperative Outcomes for Prostate Artery Embolization Versus Transurethral Resection of the Prostate and Laser Enucleation for Benign Prostatic Hyperplasia: Results from the GRAND Study.
J Clin Med 2025; 14(17)
Pyrgidis N, Puhr-Westerheide D, Schulz GB, Fabritius MP, Kazmierczak PM, Seidensticker M, Ricke J, Stief C, Weinhold P, Marcon J, Keller P

Perioperative Outcomes and Trends of Surgical Correction of Male Urethral Strictures: Results from the GRAND Study.
J Clin Med 2025; 14(7)
Bischoff R, Marcon J, Schulz GB, Stief CG, Keller P, Eismann L, Weinhold P, Pyrgidis N

The Epidemiology of Urinary Tract Trauma: Results from the GRAND Study.
J Clin Med 2025; 14(15)
Pyrgidis N, Marcon J, Schulz GB, Keller P, Volz Y, Eismann L, Bischoff R, Pfitzinger PL, Chaloupka M, Stief C, Weinhold P

Economic Burden of Imaging and Interventions in Endourology: A Worldwide Cost Analysis from European Association of Urology Young Academic Urology Endourology and Urolithiasis Working Party.
J Endourol 2025; 39(4): 389-398;
Pietropaolo A, Keller EX, Sener TE, Hamed BMZ, Tsaturyan A, Ventimiglia E, Juliebø-Jones P, Beisland C, Mikoniatis I, Tzelves L, De Coninck V, Panthier F, Chaloupka M, Bres-Niewada E, Sierra Del Rio A, Dragos L, Gadzhiev N, Shrestha A, Tursunkulov A, Ghani KR, Ketsuwan C, Danilovic A, Pauchard F, Kamkoum H, Cabrera J, Corrales M, Barghouthy Y, Kwok JL, Tokas T, Solano C, Contreras PN, Bin Hamri S, Bhojani N, Bouma-Houwert AC, Tailly T, Durutovic O, Somani BK

Urinary Outcomes of Minimally Invasive Treatments for Prostate Cancer-A Systematic Review by Young Academic Urologists' Urotechnology Working Group.
J Endourol 2025;
Taratkin M, Androsov A, Morozov A, Azilgareeva C, Rivas JG, Puliatti S, Checcucci E, Belenchon IR, Kowalewski KF, Rodler S, Piazza P, Baekelandt L, Veccia A, De Backer P, Fajkovic H, Enikeev D, Cacciamani GE

Patient Perspective on Medical Conditions Post Immune Checkpoint Therapy in Advanced Renal Carcinoma.
J Kidney Cancer VHL 2025; 12(2): 1-9;
Vaishampayan U, Pal S, Dafinescu S, Shah N, Battle D, Staehler M

Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data.
J Nucl Med 2025; 66(7): 1054-1060;
Unterrainer LM, De Leiris N, Unterrainer M, Delker A, Hempel L, Ells Z, Kunte SC, Zahner J, Holzgreve A, Zacherl MJ, Sheikh GT, Casuscelli J, Leenhardt J, Pienta KJ, Jacquet E, Laramas M, Long J, Faure M, Reboulet G, Paller CJ, Mercier A, Solnes LB, Kiraz K, Ilhan H, Gafita A, Djaileb L

PSMA PET-Positive Local Recurrences in the Prostate Bed Region and Their Coverage Based on Clinical Target Volume Delineation Guidelines from ESTRO-ACROP, PERYTON, FROGG, GFRU, and RTOG.
J Nucl Med 2025;
Moar EF, Keilholz M, Sheikh GT, Werner RA, Trapp C, Casuscelli J, Chaloupka M, Kunz WG, Kazmierczak P, Widjaja L, Brose SF, Eze C, Walter F, Belka C, Li M, Rogowski P, Schmidt-Hegemann NS

Antagonism of prostate α1A-adrenoceptors by verapamil in human prostate smooth muscle contraction.
J Pharmacol Exp Ther 2025; 392(7)
Hu S, Liu G, Kale O, Zhu W, Xu Y, Keller P, Weinhold P, Tamalunas A, Stief CG, Hennenberg M

Individualized Perioperative Blood Pressure Management in Patients Undergoing Major Abdominal Surgery: The IMPROVE-multi Randomized Clinical Trial.
JAMA 2025; 334(21): 1893-1904;
Saugel B, Meidert AS, Brunkhorst FM, Bischoff R, Esser J, Mattis M, Naue P, Vogel K, Bergholz A, Flick M, Kröker A, Müller DX, Thomsen KK, Vokuhl C, Wegge M, Bratke S, Graeßner M, Jungwirth B, Schmid S, Grundmann CD, Wischermann JM, Kellner P, Steinhaus M, Grüßer L, Coldewey SM, Zacharowski K, Meybohm P, Habicher M, Zarbock A, Zitzmann A, Letz S, Neumann C, Larmann J, Renné T, Krause L, Vettorazzi E, Zapf A, Carlstedt A, Sessler DI, Kouz K, IMPROVE-multi Trial Group

Multinational Attitudes Toward AI in Health Care and Diagnostics Among Hospital Patients.
JAMA Netw Open 2025; 8(6)
Busch F, Hoffmann L, Xu L, Zhang LJ, Hu B, García-Juárez I, Toapanta-Yanchapaxi LN, Gorelik N, Gorelik V, Rodriguez-Granillo GA, Ferrarotti C, Cuong NN, Thi CAP, Tuncel M, Kaya G, Solis-Barquero SM, Mendez Avila MC, Ivanova NG, Kitamura FC, Hayama KYI, Puntunet Bates ML, Torres PI, Ortiz-Prado E, Izquierdo-Condoy JS, Schwarz GM, Hofstaetter JG, Hide M, Takeda K, Peric B, Pilko G, Thulesius HO, Lindow T, Kolawole IK, Olatoke SA, Grzybowski A, Corlateanu A, Iaconi OS, Li T, Domitrz I, Kepczynska K, Mihalcin M, Fašaneková L, Zatonski T, Fulek K, Molnár A, Maihoub S, da Silva Gama ZA, Saba L, Sountoulides P, Makowski MR, Aerts HJWL, Adams LC, Bressem KK, COMFORT consortium , Navarro ÁA, Águas C, Aineseder M, Alomar M, Al Sliman R, Anand G, Angkurawaranon S, Aoki S, Arkoh S, Ashraf G, Astri Y, Bakhshi S, Bayramov NY, Billis A, Bitencourt AGV, Bolejko A, Bollas Becerra AJ, Bwambale J, Capela A, Cau R, Chacon-Acevedo KR, Chaunzwa TL, Chojniak R, Clements W, Cuocolo R, Dahlblom V, Sousa KM, Villarrubia JE, Desai VB, Dhakal AK, Dignum V, Andrade RGF, Ferraioli G, Ganguly S, Garg H, Savevska CG, Radovikj MG, Gkartzoni A, Gorospe L, Griffin I, Hadamitzky M, Ndahiro MH, Hering A, Hochhegger B, Huseynova MR, Ishida F, Jha N, Jiang L, Kader R, Kavnoudias H, Klein C, Kolostoumpis G, Koshy A, Kruger NA, Löser A, Lucijanic M, Mantziari D, Margue G, McFadden S, Miyake M, Morakote W, Ngabonziza I, Nguyen TT, Niehues SM, Nortje M, Palaian S, Pentara NV, de Almeida RPP, Poma G, Purwoko M, Pyrgidis N, Rafailidis V, Rainey C, Ribeiro JC, Agudelo NR, Sado K, Saidman JM, Saturno-Hernandez PJ, Suryadevara V, Schulz GB, Soric E, Soto-Pérez-Olivares J, Stanzione A, Struck JP, Takaoka H, Tanioka S, Huyen TTM, Truhn D, van Dijk EHC, van Wijngaarden P, Wang YC, Weidlich M, Zhang S

Health-Related Internet Use Among Outpatients Undergoing Cancer Treatment During the COVID-19 Pandemic: Cross-Sectional Survey Study.
JMIR Hum Factors 2025;
Erickson N, Nasseh D, Seynstahl S, Jost N, Wuerstlein R, Casuscelli J, Theurich S, Heinemann V, Fey T

Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial.
Lancet 2025; 406(10516): 2221-2234;
De Santis M, Palou Redorta J, Nishiyama H, Krawczyński M, Seyitkuliev A, Novikov A, Guerrero-Ramos F, Zukov R, Kato M, Kawahara T, Goeman L, Puente J, Hellmis E, Powles T, Radziszewski P, Gust KM, Vasey P, Bigot P, Fradet Y, Hunting J, Armstrong J, Boulos S, Hois S, Shore ND, POTOMAC Investigators

Differentiation of Tumors of the Upper Respiratory Tract Using Optical Metabolic Imaging.
Lasers Surg Med 2025; 57(2): 147-153;
Eggert D, Gaertner D, Rühm A, Sroka R, Arens C, Davaris N, Birkmeier K, Brodschelm A, Leisching P, Studier H, Becker W, König K, Betz CS

[Diagnostic algorithm and key differential diagnoses of hematuria].
MMW Fortschr Med 2025; 167(1): 42-46;
Hermans J, Stief CG, Schulz GB

[Flank pain: diagnostics for general practitioners].
MMW Fortschr Med 2025; 167(1): 36-41;
Kidess M, Ivanova T, Blajan I, Karatas D, Papadopoulos I, Chaloupka M, Stief CG, Ebner B

[From Muscle-Invasive to Metastatic Disease: Modern Management of Urothelial Carcinoma].
MMW Fortschr Med 2025; 167(17): 42-45;
Semmler M, Kolligs F, Stief CG, Casuscelli J

[Kidney stones: Diagnosis in the general practitioner's office and further procedure].
MMW Fortschr Med 2025; 167(1): 47-49;
Blajan I, Ebner B, Ivanova T, Apfelbeck M, Karatas D, Stief CG, Chaloupka M

[Editorial].
MMW Fortschr Med 2025; 167(17)
Casuscelli J

[Editorial].
MMW Fortschr Med 2025; 167(1)
Stief CG

[Therapy of non-muscle-invasive Bladder Cancer].
MMW Fortschr Med 2025; 167(17): 40-41;
Kidess M, Ebner B, Volz Y, Hermans J, Eismann L, Karatas D, Takayama-Fouladgar S, Stief CG, Schulz GB

Awareness and use of generative AI-powered tools: results of one-year follow-up prospective cross-sectional global survey.
Minerva Urol Nephrol 2025; 77(4): 528-537;
Cei F, Ganjavi C, Layne E, Hussari T, Gevorkyan RR, Eppler M, Piazza P, Rodler S, Checcucci E, Gomez Rivas J, Kowalewski KF, Rivero Belenchón I, Puliatti S, Taratkin M, Veccia A, Baekelandt L, DE Backer P, Teoh J, Somani B, Wroclawski M, DE Castro Abreu A, Briganti A, Salonia A, Montorsi F, Porpiglia F, Murphy D, Canes D, Gill I, Cacciamani GE

Spatial expression of HER2, NECTIN4, and TROP-2 in Muscle-Invasive Bladder Cancer and metastases: Implications for pathological and clinical management.
Mod Pathol 2025;
Dernbach G, Eich ML, Dragomir MP, Anders P, Jurczok N, Stief C, Jurmeister P, Schlomm T, Klauschen F, Horst D, Schulz GB, Schallenberg S

Mechanistic insights into 5-aminolevulinic acid photodynamic therapy for acne vulgaris: targeting lipogenesis via the OLR1-Wnt/β-catenin pathway.
Mol Med 2025; 31(1)
Yan J, Zhang L, Zeng Q, Qian Y, Li K, Liu X, Wu Y, Yan Y, Zhang H, Cheung S, Liu J, Sroka R, Wang X, Shi L

Target and off-target effects of vibegron on smooth muscle contraction of human detrusor and prostate tissues.
Naunyn Schmiedebergs Arch Pharmacol 2025;
Hu S, Xu Y, Brandstetter M, Tamalunas A, Kale OE, Keller P, Stadelmeier LF, Weinhold P, Stief CG, Hennenberg M

Adjustable TransObturator Male System (ATOMS) After Radiotherapy: Is Timing Everything? A Single-Center Experience.
Neurourol Urodyn 2025; 44(8): 1614-1620;
Kidess M, Lederer E, Pyrgidis N, Georgieva T, Hermans J, Stadelmeier L, Hoffmann M, Ebner B, Keller P, Chaloupka M, Marcon J, Weinhold P, Bauer R, Stief CG, Volz Y

β3-Adrenoceptor Agonist Effects on the Urinary Bladder Beyond Detrusor Relaxation.
Neurourol Urodyn 2025;  44(7): 1498-1502
Michel MC, Arioglu-Inan E, Hennenberg M

Prognostic impact of combined loss of RB1, p53 and p21 in muscle-invasive bladder cancer.
Pathol Res Pract 2025
Ebner B, Eismann L, Hermans J, Kidess M, Pyrgidis N, Semmler M, Volz Y, Buchner A, Chaloupka M, Eich ML, Weinhold P, Stief CG, Horst D, Schulz GB, Schallenberg S.

Benzyl Benzoate Isolation from Acridocarpus smeathmannii (DC.) Guill. & Perr Roots and Its Bioactivity on Human Prostate Smooth Muscle Contractions.
Pharmaceuticals (Basel) 2025; 18(5)
Kale OE, Rauanov I, Huber C, Tamalunas A, Stief CG, Eisenreich W, Hennenberg M

Pine-Extracted Phytosterol β-Sitosterol (APOPROSTAT® Forte) Inhibits Both Human Prostate Smooth Muscle Contraction and Prostate Stromal Cell Growth, Without Cytotoxic Effects: A Mechanistic Link to Clinical Efficacy in LUTS/BPH.
Pharmaceuticals (Basel) 2025; 18(12)
Tamalunas A, Schierholz F, Poth H, Vigodski V, Brandstetter M, Ciotkowska A, Rutz B, Hu S, Stadelmeier LF, Schulz H, Ledderose S, Rogenhofer N, Kolben T, Stief CG, Hennenberg M

Vasoactivity of Rac GTPase, Cytohesin and Kinase Inhibitors in Renal Interlobar and Coronary Arteries Reveals Shared and Distinct Patterns of Inhibitory Effects in Vascular and Prostate Smooth Muscle Contraction.
Pharmacol Res Perspect 2025; 13(6)
Liu G, Hu S, Tamalunas A, Kale O, Xu Y, Stief CG, Hennenberg M

Investigations on MRI changes after 5-aminolevulinic acid mediated interstitial photodynamic therapy for malignant gliomas.
Photochem Photobiol Sci 2025; 24(12): 2135-2152;
El Fahim M, Foglar M, Stepp H, Buchner A, Quach S, Bochmann K, Thon N, Sroka R, Rühm A, Forbrig R, Aumiller M

Efficacy of ALA-PDT for Epidermoid Cyst on the Face: A Retrospective Study.
Photodiagnosis Photodyn Ther 2025;
Zhang H, Yan Y, Zhao Y, Zhou Z, Gao J, Sroka R, Zhang L, Wang X

Comparison of PSA Values from capillary dried blood spot analysis and venous serum samples.
PLoS ONE 2025; 20(10):e0335448
Engelage L, Behnel N, Lumiani A, Tamalunas A, Buchner A, Sroka R

Perioperative outcomes of HoLEP, ThuLEP, and TURP in patients with prostate cancer: results from the GRAND study.
Prostate Cancer Prostatic Dis 2025;
Pyrgidis N, Schulz GB, Weinhold P, Atzler M, Stadelmeier LF, Papadopoulos I, Stief C, Marcon J, Keller P

Propensity score-matched evaluation of palliative transurethral resection and holmium laser enucleation of the prostate for bladder outlet obstruction in patients with prostate cancer.
Prostate Cancer Prostatic Dis 2025; 28(1): 153-159;
Tamalunas A, Keller P, Schott M, Stadelmeier LF, Kidess M, Atzler M, Ebner B, Hennenberg M, Stief CG, Magistro G

[Options in nuclear medicine for advanced prostate cancer in practice].
Radiologie (Heidelb) 2025; 65(11): 877-886;
Siegmund SC, Kazmierczak PM, Holzgreve A, Stief CG, Casuscelli J, Unterrainer M, Unterrainer LM

Refining prognostic stratification in salvage radiotherapy for prostate cancer: a retrospective multicenter cohort study using PSMA-PET and machine learning.
Radiother Oncol 2025;
Medici F, Aebersold DM, Casuscelli J, Emmett L, Fanti S, Farolfi A, Guckenberger M, Hruby G, Koerber SA, Thoma SA, Peeken JC, Rogowski P, Scharl S, Shelan M, Spohn SKB, Strouthos I, Vogel M, Wiegel T, Zamboglou C, Schmidt-Hegemann NS, Morganti AG, Cilla S

The Prognostic Value of Perioperative Factors on Biochemical Recurrence in Patients Undergoing Radical Prostatectomy.
Res Rep Urol 2025; 17(): 185-194;
Pyrgidis N, Weinhold P, Schulz GB, Chaloupka M, Berg E, Westhofen T, Rodler S, Keller P, Jokisch F, Stief CG, Marcon J, Bischoff R

Real-world analysis of immune checkpoint inhibitor efficacy and response predictors in patients treated at the CCCMunichLMU outpatient clinic.
Sci Rep 2025; 15(1)
Dorman K, Breitenwieser K, Fischer L, Zhang D, Probst V, Weiss L, Heinrich K, Kunz WG, Holch JW, Gießen-Jung C, Haas M, Boeck S, von Bergwelt-Baildon M, Landfarth T, Hornung R, Casuscelli J, Berger-Thürmel K, Heinemann V, Westphalen CB, Reischer A

Smooth muscle contractility of laser-enucleated prostate tissues and impacts of preoperative α1-blocker treatment in patients with and without catheterization.
Sci Rep 2025; 15(1)
Keller P, Hu S, Berger L, Nicola P, Schierholz F, Tamalunas A, Kale OE, Weinhold P, Waidelich R, Stief CG, Hennenberg M

Prophylactic Use of Biologic Mesh in Ileal Conduit (PUBMIC trial).
Transl Androl Urol 2025; 14(2): 210-213;
Pyrgidis N, Schulz GB, Stief CG, Weinhold P, Marcon J

Gender-Specific Differences in Recurrence and Progression following Bacillus Calmette-Guérin Instillation for Non-Muscle-Invasive Bladder Cancer.
Urol Int 2025; 109(4): 412-424;
Schneidewind L, Kiss B, Kranz J, Zengerling F, Borkowetz A, Graf S, Graser A, Uhlig A

Real-World Insights: Balancing Diagnostic Benefits and Oncological Risks of Ureteroscopic Biopsy before Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
Urol Int 2025;
Bohn L, Nofal M, Ledderose S, Schulz GB, Bischoff R, Kazmierczak PM, Chaloupka M, Casuscelli J, Waidelich R, Stief CG, Rodler S, Eismann L, Ebner B

The Impact of Ureteral Access Sheaths on Radiation Exposure in the Ureterorenoscopic Treatment of Urolithiasis.
Urol Int 2025; 109(4): 330-336;
Eismann L, Rodler S, Buchner A, Strittmatter F, Alghamdi A, Lennartz S, Grunz JP, Waidelich R, Becker A, Weinhold P, Kretschmer A, Stief CG, Westhofen T

The role of radical cystectomy with orthotopic neobladder reconstruction in patients developing bladder cancer after prior radical prostatectomy, radiation therapy or BPH surgery.
Urol Int 2025; 109(6): 566-575;
Pyrgidis N, Volz Y, Takayama Fouladgar S, Ebner B, Weinhold P, Marcon J, Chaloupka M, Stief CG, Schulz G, Keller P

Association of interleukin-6 serum levels with local tumor stage and lymph node metastasis of urothelial carcinoma.
Urol Oncol 2025; 43(12): 693.e1-693.e8;
Ebner B, Hirsch J, Holz A, Volz Y, Eismann L, Hermans J, Pyrgidis N, Kidess M, Semmler M, Fouladgar ST, Papadopoulos I, Chaloupka M, Apfelbeck M, Marcon J, Weinhold P, Ewert A, Kazmierczak P, Stief CG, Schulz GB

Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think Tank.
Urol Oncol 2025; 43(11): 639-653;
Shapiro DD, Abel EJ, Albiges L, Battle D, Berg SA, Campbell MT, Cella D, Coleman K, Garmezy B, Geynisman DM, Hall T, Henske EP, Jonasch E, Karam JA, La Rosa S, Leibovich BC, Maranchie JK, Master VA, Maughan BL, McGregor BA, Msaouel P, Pal SK, Perez J, Plimack ER, Psutka SP, Riaz IB, Rini BI, Shuch B, Simon MC, Singer EA, Smith A, Staehler M, Tang C, Tannir NM, Vaishampayan U, Voss MH, Zakharia Y, Zhang Q, Zhang T, Carlo MI

Radiomic biomarkers associated with immune checkpoint blockade response for advanced renal cell carcinoma.
Urol Oncol 2025; 43(12): 708.e15-708.e24;
Reese SW, Barbakoff D, Ucpinar BA, Knezevic A, Fitzgerald K, Eismann L, Tehrani YM, Arroyave JS, Khaleel S, Khandwala YS, Dawidek M, Motzer RJ, Voss MH, Russo P, Akin O, Kotecha RR, Hakimi AA

Higher Risk Renal Angiomyolipomas: Surveillance Remains a Safe Management Option.
Urol Pract 2025; 12(2): 274-280;
Dawidek MT, Villada JSA, Vazquez-Rivera K, Fuchs H, Calderon LP, Eismann L, Reese SW, Ganz M, Ridouani F, Ostrovnaya I, Touijer KA, Coleman JA, Russo P, Hakimi AA

Tumors in Solitary Kidneys Are Not All Equal: Outcomes of Partial Nephrectomy in High-Risk Cases.
Urol Pract 2025; 12(4): 441-450;
Dawidek MT, Calderon LP, Arroyave Villada JS, Ucpinar BA, Eismann L, Reese SW, Ganz M, Akin O, Reznik E, Coleman JA, Hakimi AA, Russo P

[Balancing family and career for female physicians in Germany: insights from a survey of female urologists].
Urologie 2025; 64(2): 157-164;
Wiemer L, Knipper S, Herlemann A, Welte MN, Siech C, Greiser EM, Müller K, Bellut L, Schönburg S, Walach M, Pompe R, Weinberger S

[Options in nuclear medicine for advanced prostate cancer in practice].
Urologie 2025; 64(9): 976-985;
Kunte SC, Kazmierczak PM, Holzgreve A, Stief CG, Casuscelli J, Unterrainer M, Unterrainer LM

Efficacy of Drug-coated Balloon Dilation Versus Endoscopic Standard Treatment in Posterior Urethral Stenosis: A Real-world Comparative Study.
Urology 2025;  206: 164-170;
Berg EK, Mehmedovic S, Askari D, Hermans J, Hoffmann MA, Keller P, Marcon J, Weinhold P, Stief CG, Eismann L, Bischoff R

Awareness and prevalence of testicular cancer among German firefighters.
World J Urol 2025; 43(1)
Kidess M, Elser T, Aschl F, Gonder S, Pyrgidis N, Volz Y, Ebner B, Hermans J, Marcon J, Schulz GB, Weinhold P, Stief CG, Apfelbeck M, Chaloupka M

Discrepancies between physician-assessed and patient-reported complications after cystectomy - a prospective analysis.
World J Urol 2025; 43(1)
Ebner B, Hirsch J, Holz A, Volz Y, Eismann L, Hermans J, Pyrgidis N, Kidess M, Semmler M, Brinkmann I, Aydogdu C, Chaloupka M, Lindner AK, Weinhold P, Stief CG, Schulz GB

Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year study.
World J Urol 2025; 43(1)
de Angelis M, Pellegrino F, Scilipoti P, Longoni M, Santangelo A, Subiela JD, Contieri R, Afferi L, Zamboni S, Suardi N, Musi G, Luzzago S, D'Andrea D, Laukhtina E, Soria F, Gontero P, Del Giudice F, Khan MS, Thurairaja R, Roupret M, Grobet-Jeandin E, Baudewyns A, Tanaka H, Matsumoto S, Fujii Y, Proietti F, Simone G, Schulz GB, Pyrgidis N, Ploussard G, Antonelli A, Bertolo R, Roumiguie M, Bajeot AS, Mir MC, Umari P, Teoh J, Wong C, Mertens LS, Pichler R, Mori K, Ślusarczyk A, Poyet C, Albisinni S, Aziz A, Volpe A, Shariat S, Pradere B, Karakiewicz P, Resca S, Beatrici E, De Groote R, Mottrie A, Necchi A, Montorsi F, Briganti A, Moschini M, European Association of Urology–Young Academic Urologists Urothelial Carcinoma Working Group (EAU-YAU)

Silencing of Rac1 and Arf6 reduces time-dependent and carbachol-induced contractions, proliferation, survival and growth in human bladder smooth muscle cells.
World J Urol 2025; 43(1)
Qian S, Hu S, Zhu W, Tamalunas A, Stief CG, Hennenberg M

Physical activity matters: prognostic impact of preoperative functioning scores in patients undergoing radical cystectomy.
World J Urol. 2025; 43(1)
Volz Y, Eismann L, Westhofen T, Pyrgidis N, Pfitzinger PL, Hermans J, Ebner B, Jokisch JF, Weinhold P, Bischoff R, Chaloupka M, Keller P, Buchner A, Schulz GB, Stief CG, Marcon J

TERT expression in human prostate tissue reveals a potential molecular switch in benign prostatic hyperplasia progression.
World J Urol 2025; 44(1)
Xu Y, Hu S, Berger L, Nicola P, Weinhold P, Tamalunas A, Stief CG, Hennenberg M, Keller P